Tag: Vaccine
Share Skyrockets on news of positive early-stage results from GEN-009 Clinical...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate....